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IN his original description of the disease induced by the virus he isolated,
Rauscher (1962) emphasized its biphasic nature. An early splenic phase*, unless
fatal, was almost invariably followed several months later bylymphatic leukaemia.
However, when rats or C57BL/6 mice were inoculated they developed only
lymphatic leukaemia after a long latent period. It was postulated by Rauscher
that this unusual dual response in the same mouse might be due to the presence of
two viruses, each responsible for the induction of separate diseases. However, he
could find no experimental evidence to support this hypothesis.
Subsequent investigators (Boiron et al., 1965; Mirand et al., 1965; Dmochowski
et al., 1966), with one exception (Siegler and Rich, 1964), could not demonstrate
the development of lymphatic leukaemia in groups of mice in which the splenic
phase of Rauscher disease had occurred. However, it was confirmed that the
Rauscher virus induced only lymphatic leukaemia in rats.
Rauscher had also noted that the early splenic response in BALB/c mice
resembled that associated with Friend disease; later it was shown that the two
viruses were closelyrelatedimmunologically (Old, BoyseandLilly, 1963). Further-
more, it has been shown that Friend virus, after inoculation into rats also induces
lymphatic leukaemia (Mirand and Grace, 1962). In more extensive studies
(Dawson, Rose and Fieldsteel, 1966; Dawson, Tacke and Fieldsteel, 1968), it was
shown that after inoculation back into BALB/c mice it was possible to induce
either Friend disease, lymphatic leukaemia or both diseases in the same mouse,
depending upon the previous passage history in rats. Finally, after prolonged
passage in rats the virus induced only lymphatic leukaemia in mice. While it
was possible to separate the agent that induced lymphatic leukaemia we were
unable to obtain a preparation of Friend virus that was incapable of inducing
lymphatic leukaemia in rats. Detailed serological studies revealed that both
agents were closely related antigenically. It was concluded that Friend virus was
probably a mixture of two related viruses, that it was probably defective and
dependent upon the presence of the lymphatic leukaemia virus which acted as a
helper. In view of the apparent similarity between Friend and Rauscher viruses
it seemed probable that the latter was also a mixture oftwo viruses. The present
report is the result of studies designed to determine if a single virus was indeed
* This splenic phase is characterized by the presence in the red pulp of the spleen of collections of
undifferentiated haematopoietic cells (reticulumcells) surroundedby various numbers oferythroblasts.
The exact nature of these changes remains controversial. To distinguish this from lymphatic
leukaemia the noncommittal terms 8plenic phase or 8plenic disea8e will be used.INDUCTION OP LYMPHATIC LEUKAEMIA IN MICE8
capable of inducing two histologically distinct diseases, or if preparations of
Rauscher virus contained a separate agent which induced lymphatic leukaemia.
MATERIALS AND METHODS
Sprague-Dawley rats, C57BL/6, BDF1 and some BALB/c mice were obtained
from Simonsen Laboratories, Gilroy, California, U.S.A. Other BALB/c mice were
from our own colony.
Initially, Rauscher virus was obtained from Dr. Frank J. Rauscher, as a 10 per
cent extract ofspleens ofBALB/c mice ofthe 16th serial passage. At a later date
we received an extract of spleens from the first 3 BALB/c mice that developed
leukaemia during his attempt to extract a virus from the Schwartz transplantable
tumour. This extract served as the source of all subsequent preparations of
Rauscher virus.
The methods used for the preparation ofvirus pools, inoculation ofanimals and
transplantation of tumours have been described previously (Fieldsteel, Dawson
and Bostick, 1963; Dawson, Rose and Fieldsteel, 1966).
RESULTS
The first virus preparation received by us from Rauscher which represented the
16th passage in BALB/c mice was inoculated as a 10 per cent splenic extract into
50 weanling BALB/c mice. They all developed palpable splenomegaly by the 8th
day after inoculation, and when killed on the 26th day, all had enormously
enlarged blood-filled spleens, which averaged 2-54 g. in weight. Grossly and
histologically the disease was indistinguishable from that seen in the spleens of
BALB/c mice inoculated with Friend virus.
Another group of 30 BALB/c mice inoculated simultaneously with a hundred-
fold dilution of the same material was observed until death. According to
Rauscher, this dilution of virus should have induced lymphatic leukaemia in a
majority of the mice. The mice died between the 33rd and 89th day after
inoculation (average = 55-5). At autopsy they all showed the typical initial
response with splenomegaly or hepatosplenomegaly, and none had signs of
lymphatic leukaemia.
Rauscher had found that the number ofmice surviving the first mortality peak
associated with hepatosplenomegaly was dependent upon both age and dose of
virus. Newborn BALB/c mice inoculated with maximal quantities ofvirus rarely
survived the initial disease. Conversely, a large proportion of young adult
BALB/c mice inoculated with smaller doses of virus survived this phase and
eventually developed lymphatic leukaemia. Therefore, an experiment was
carried out to show progression from the splenic to the leukaemic phase of the
disease. Decimal dilutions of virus from the 18th passage were inoculated into
groups of20 adult BALB/c mice. Halfofthe mice were killed 35dayslaterandthe
remainder when moribund or on the 122nd day after inoculation. The spleen
from each mouse was weighed and examined histologically. The virus titre at
35 days was 10-5 2/ml. All the mice showed splenicdisease, except one inoculated
with the 10-6 dilution and killed 122 days later. It showed early lymphatic
leukaemia.
In a later experiment with this same pool of virus another mouse inoculated
with a 10-6 dilution of virus died 84 days later with a huge thymus typical of
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lymphatic leukaemia. However, there were also the typical changes of early
splenic disease. When an extract of the thymus was inoculated into 8 weanling
BALB/c mice, 6 of them developed typical splenic disease and the remaining 2
were normal when killed 194 days later. Two serial passages in weanling BALB/c
mice of extracts of enlarged spleens from this group of mice resulted only in the
splenic form of Rauscher disease even though deaths occurred as late as 191 days
after inoculation.
Since Rauscher virus reportedly did not induce the early splenic response in
either C57BL/6 mice or in rats (Rauscher, 1962), groups of these animals were
inoculated with the virus to determine ifour preparations were capable ofinducing
lymphatic leukaemia in more than an occasional mouse. The results are shown
in Table I. All animals which developed disease had typical lymphatic leukaemia
TABLE I.-Results of Inoculation of Rauscher Virus into C57BL/6 Mice
and Sprague-Dawley Rats
Number Average Number
with time to with
Age Number lymphatic death splenic
Animals (days) inoculated leukaemia (days) disease
C57BL/6 mice* . . 1-7 . 19 . 15 . 221 . 0
Sprague-Dawley ratst . 1-9 . 17 . 11 . 131 . 0
* Inoculated with virus from the 18th passage in BALB/c mice.
t Inoculated with virus from the 17th passage in BALB/c mice.
both grossly and histologically. None showed the splenic phase of Rauscher
disease. Since the virus obviously had the capability to induce lymphatic
leukaemia an attempt was again made to induce both it and the splenic form of
disease in the same group of animals. For this experiment BDF1 hybrid mice
were used. It was felt because they are the offspring of C57BL/6 mice which
were shown to develop lymphatic leukaemia and DBA/2 mice which Rauscher
had shown to be highly susceptible to the splenic form of the disease, that they
might be likely to develop both diseases. Young adult BDF1 mice were inoculated
with virus from the 18th mouse passage. Ten mice were killed 33 days later and
at autopsy their spleens appeared normal. All showed microscopically small foci
of proliferating reticulum cells typical of the splenic form of Rauscher disease.
The remaining 12 mice were observed for 619 days. During that period 1 mouse
died 65 days after inoculation with splenic disease. The other mice survived until
killed on the 619th day. Six were normal. Two had gross splenic disease. Two
others which had normal sized spleens showed microscopic evidence ofthe splenic
form of Rauscher disease which had regressed. The last mouse had a small
abdominal tumour with a slightly enlarged spleen; microscopically these and the
liver showed lymphatic leukaemia. There was no indication that any of these
mice had developed both diseases.
The lymphatic leukaemia-inducing virus isolated from rats was investigated
further because after passage it readily induced the disease in virtually all in-
oculated newborn rats with a relatively short latent period. At the 9th passage
it induced lymphatic leukaemia in all 29 rats inoculated, with a latent period of
93 days. It was possible also to demonstrate that the lymphatic leukaemia could
be transmitted to the uninoculated offspring of rats inoculated with this virus.
In one instance a female, inoculated when less than 24 hours old, had a litter of 6,
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104 days post-inoculation. One of the latter died when 122 days of age with a
thymic tumour around 30 mm. in diameter. Histologically, this was a lymphoma,
which also involved the parasternal muscles. A second member of the litter died
when 157 days of age and it also had a massive thymic lymphoma.
After varying numbers of passages of the virus in rats, it was inoculated back
into either newborn or young adult BALB/c mice with the results shown in
Table II. One mouse had a questionable splenic response along with lymphatic
TABLE II.-Results ofPassage of Rauscher Virus in Mice after Previous
Passage in Sprague-Dawley Rats
Number with
Passage history Age at Total Lymphatic Splenic Myeloid
of inoculum inoculation inoculated leukaemia disease leukaemia
M17RI . nb 49 . 43 0 1
ya . 10 . 3 0 0
R8 . . ya 16 . 12 0 0
R8M1. ya . 39 . 4 0 0
R9 . . nb 35 . 35 1?* 0
M = Passages in BALB/c mice.
R = Passages in Sprague-Dawley rats.
nb = Newborn.
ya = Young adult.
* This mouse had definite lymphatic leukaemia and questionable erythroid leukaemia in the spleen.
leukaemia, 1 had myeloid leukaemia, and the remainder with disease hadlymphatic
leukaemia.
This apparent rapid conversion ofthe virus to a lymphatic leukaemia-producing
agent in mice after only 1 passage in rats suggested even more strongly that 2
viruses were involved. It was highly unlikely that a single agent which induced
only splenic disease in mice would be unable to induce this disease again after only
1 passage in rats. It seemed more probable that a lymphatic leukaemia-inducing
agent was also present in the mice but was masked by the very short latent period
of the splenic disease-inducing agent. The former then became apparent only
when preparations containing both agents were inoculated into a host relatively
resistant to the latter.
The simplest way to resolve this problem would be to demonstrate that the
original virus carried in BALB/c mice was indeed capable of inducing both types
of leukaemia, and that 2 strains of virus could be obtained each of which would
consistently produce only 1 type of disease. Since our preparations of Rauscher
virus had not induced overt lymphatic leukaemia in BALB/c mice, we requested
Dr. Rauscher to send us the earliest available passage of the virus. This extract,
which came from the original BALB/c mice with Rauscher disease, when inoculated
into newborn BALB/c mice by Rauscher in 1962, induced splenomegaly in 100 per
cent of recipients within 30 days. Five mice of this group which survived the
early splenomegalic phase developed tvpical lymphatic leukaemia. We received
this material after 5 years storage at -70° C. Following inoculation into newborn
mice (Table III) there was a greatly extended latent period, probably due to loss
of viability during storage. However, 9 mice developed the splenic disease and
3 developed lymphatic leukaemia. In addition, 160 days after inoculation, 1 of
the former developed a subcutaneous reticulum cell sarcoma over the right
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TABLE III.-Results of Inoculation of Original Rauscher Virus into
Newborn BALB/c Mice
Splenic disease Lymphatic leukaemia
Passage
A A_____-___A
number of Number Average time Average time
inoculum inoculated Number to death Number to death
1* . 15 . 9§ 217 . 3 258
2t . 7 . 6 39 . 1 286
21 . 12 . 0 . 6 206
* Splenic extract from the original 3 mice to develop the disease described by Rauscher in BALB/c
mice.
t Splenic extract from a mouse in passage 1 that had typical splenic disease.
+ Splenic extract from a mouse in passage 1 that had typical lymphatic leukaemia.
§ One of these mice also developed a subcutaneous reticulum cell sarcoma over the right scapula.
scapula. Histologically this tumour closely resembled the reticulum cell sarcomas
induced by Friend virus. It was readily transplantable and cell-free extracts
from it induced the typical splenic phase ofRauscher disease, but did not give rise
to local tumour formation.
A 2nd passage of the virus was made from the spleen of 1 of the mice which
showed the splenic phase of the disease only. Six of the recipients developed
splenic disease with a typically short latent period. The 7th mouse died of
lymphatic leukaemia on day 286. A 2nd passage was also made from an extract
ofthe spleen and enlarged mesenteric node from a mouse in the 1st passage which
had lymphatic leukaemia. Six mice developed lymphatic leukaemia with a mean
time to death of 206 days. None of this group developed splenic disease.
From several ofthe BALB/c mice with lymphatic leukaemia it was possible to
induce readily transplantable lymphomas from their mesenteric lymph nodes.
An experiment was carried out to determine the relationship between these
lymphomas and those induced by the lymphatic leukaemia virus associated with
Friend virus. A group of BALB/c mice were inoculated twice, 14 days apart,
with viable cells from a Friend virus-induced lymphoma from RF mice. This
tumour did not take in BALB/c mice but has been shown by us (unpublished data)
to protect them against the isologous lymphoma from BALB/c mice. Control
groups received either normal liver cells from RF mice or nothing. Two weeks
after the second inoculation all groups were challenged i.p. with either 5 X 103 or
1 X 104 viable lymphoma cells from the Rauscher virus-induced lymphoma.
The Friend virus-inducedlymphoma conferred complete transplantation resistance
against the Rauscher virus-induced lymphoma (Table IV).
TABLE IV.-Transplantation Resistance Against Rauscher Virus Lymphoma
in BALB/c Mice Pretreated with a Friend Virus Lymphoma
Results of challenge with indicated number of viable
cells of Rauscher virus lymphomat
Immunization* 5 x 103 1 x 104 Totals
FV lymphoma. . 0/15 0/15 0/30
Normal liver . . 10/15 11/15 21/30
None . . 14/15 11/15 25/30
* Days 0 and 14 mice received respectively 4-7 x 107 and 1 1 x 108 viable cells, S.C., from either
Friend virus induced lymphoma from RF mice, or normal liver cells from RF mice.
t Day 28 inoculated i.p. with Rauscher virus-induced lymphoma cells from BALB/c mice.
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DISCUSSION
The present investigation was carried out in an attempt to resolve apparently
conflicting evidence concerning the biphasic nature of the leukaemia caused by
Rauscher virus, and to derive some explanation for what appeared to be a series
of anomalies. In essence, the problem was to explain the divergence of results
between those of Rauscher and later workers.
In one initial experiment with virus from the 18th passage in BALB/c mice we
could not confirm Rauscher's observation that up to 70 per cent of these mice
later developed lymphatic leukaemia, but we could show that rats and C57BL/6
mice inoculated with this virus uniformly developed lymphatic leukaemia.
Basically our results were identical with those obtained with the closely related
Friend virus where one sees only the splenic disease in BALB/c mice and lymphatic
leukaemia in rats and certain other strains of mice. Since there is now good
evidence to indicate that these 2 diseases may be caused by different viruses
(Dawson, Tacke and Fieldsteel, 1968) we felt it was not unreasonable to assume
that Rauscher virus was a mixture of 2 viruses, one that caused reticulum cell
proliferation within the spleen and one that induced lymphatic leukaemia.
Furthermore, since we have induced both diseases in the same mice inoculated
with early rat-passaged Friend lymphatic leukaemia virus it was possible that an
analogous situation existed with early mouse-passaged Rauscher virus originating
from the Schwartz lymphatic leukaemia-inducing material.
When we inoculated BALB/c mice with the 1st passage of Rauscher's original
isolate we were able to induce splenic disease in 75 per cent of the mice and
lymphatic leukaemia in the remainder. Unlike Rauscher, however, we did not
see both diseases in the same animal, although we did subsequently, on one
occasion.
The significance of the reticulum cell sarcoma arising in I mouse of this group,
is uncertain. Although the spontaneous occurrence of such a tumour is most
unusual, its location was such as to make it unlikely that it was directly related to
the original inoculation. Since this mouse was shown to have the splenic phase
of Rauscher disease it was not unexpected that the tumour could be incidentally
contaminated with the virus. However, it does seem more than coincidental that
histologically the tumour should so closely resemble the Friend virus-induced
reticulum cell sarcomas.
It was relatively simple to make separate serial passages of each of the splenic
and lymphatic leukaemia agents in BALB/c mice, and to induce transplantable
lymphomas from the latter. Additionally, a lymphoma induced by the Friend
lymphatic leukaemia agent was able to confer upon BALB/c mice complete
transplantation resistance against the Rausclher lymphoma.
Thus, it was apparent that early passage Rauscher virus was indeed capable of
inducing lymphatic leukaemia in BALB/c mice. A probable explanation for the
failure of later passages of the virus to induce this disease in BALB/c mice is
twofold. First, it seems likely that early isolates contained a preponderance of
particles inducing lymphatic leukaemia and that this virus was able to replicate
more readily in BALB/c mice. Second, the agent inducing splenic disease was
present in only small quantities and required several passages in mice for adapta-
tion. Therefore it was possible for the former, which has a longer latent period,
to induce disease. As the latter became adapted by passage in BALB/c mice, the
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animals developed splenic disease and died before they developed lymphatic
leukaemia. Since the lymphatic leukaemia virus was not actually lost in passage,
as shown by the ability oflater passages to induce this disease in animals resistant
to the reticulum cell disease, it is probable that the agent continued to be carried
along replicating at a slow rate, but not developing to the point of inducing overt
disease.
Still apparently unresolved is Rauscher's observation of both diseases in the
same mice. Diagnosis of splenic disease in mice thav later developed lymphatic
leukaemia was based solely on the fact that these mice had early palpable spleens,
did not die, and later developed lymphatic leukaemia. There was no histological
evidence in the latter of resolved early disease presented by either Rauscher, or
later by Dunn and Green (1966). Further, evidence of splenomegaly was based
on palpation and spleens approximately twofold enlarged were considered to be
evidence of the reticulum cell disease. It is possible that either a non-specific
response occurred early in some animals or that abortive non-progressive splenic
disease occurred. The latter seems unlikely in view of our findings in BDF1 mice
that as late as 619 days after inoculation microscopic evidence ofregressed splenic
disease could still be detected microscopically. Therefore, since no histological
evidence of dual disease was presented, it must be assumed that 2 viruses caused
2 different diseases, and that only in exceptional instances did both diseases occur
in the same animal.
SUMMARY
The reported dual ability of Rauscher virus to induce early splenic (reticulum
cell) disease followed by lymphatic leukaemia in BALB/c mice, was investigated.
Virus from the 16th-18th passage induced only splenic disease. When inoculated
into newborn C57BL/6 mice and rats only lymphatic leukaemia occurred. Rat-
passaged virus also induced only lymphatic leukaemia upon inoculation back into
BALB/c mice.
When Rauscher's original 1st passage isolate was later inoculated into newborn
BALB/c mice, both splenic disease and lymphatic leukaemia occurred, but
generally not in the same animals. Each type of disease was then readily re-
produced separately upon serial passage in BALB/c mice. Transplantable
lymphomas were induced from lymph nodes of mice with lymphatic leukaemia.
These lymphomas were shown to be relatedtolymphomasinducedbythelymphatic
leukaemia virus associated with Friend virus.
It was concluded that Rauscher virus is probably a mixture of at least 2
viruses, one of which induces the early splenic response, and the other lymphatic
leukaemia. The latter, although present in later passages of the virus, could not
produce overt disease because ofits relatively long latent period as compared with
that of the quick-acting splenic disease virus.
We are most grateful to Dr. Frank J. Rauscher whose co-operation made this
work possible. We are indebted to Mrs. Anna Lisa Arecco and Mrs. Jean
McClellan for skilled technical assistance.
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